Degeneration of the external cuneate nucleus in spinocerebellar ataxia type 3 (Machado-Joseph disease)

被引:26
|
作者
Rüb, U
de Vos, RAI
Brunt, ER
Schultz, C
Paulson, H
Del Tredici, K
Braak, H
机构
[1] Goethe Univ Frankfurt, Dept Clin Neuroanat, D-60590 Frankfurt, Germany
[2] Lab Pathol Oost Nederland, NL-7512 AD Enschede, Netherlands
[3] Univ Groningen, Univ Hosp Groningen, Dept Neurol, NL-5970 RB Groningen, Netherlands
[4] Univ Iowa, Coll Med, Dept Neurol, Iowa City, IA 52242 USA
关键词
ataxin; Machado-Joseph disease; proprioception; somatosensory system; SCA3;
D O I
10.1016/S0006-8993(02)03278-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Owing to its anatomical connections, the external cuneate nucleus (ECU) plays a crucial role in processing proprioceptive input from the upper trunk and upper limbs. Here, we studied this dorsal column nucleus post-mortem in five individuals with clinically diagnosed and genetically confirmed spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease, who had manifested upper trunk and upper limb ataxia. Polyethylene glycol-embedded 100-mum sections stained for lipofuscin pigment and Nissl material, as well as paraffin-embedded Nissl-stained thin sections, revealed serious neuronal loss in the ECU of all live SCA3 patients. As observed in other affected central nervous system structures, the ECU of these individuals displayed an astrogliosis, and some of the few surviving neurons harbored one or even two ataxin-3-immunopositive intranuclear inclusion bodies. The findings of the present study suggest that (1) the ECU is among the consistent targets of the degenerative process underlying SCA3 and (2) interruption of the proprioceptive pathway at the level of the ECU contributes significantly to upper limb and trunk ataxia in SCA3 patients. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:126 / 134
页数:9
相关论文
共 50 条
  • [21] Identification of a potential exosomal biomarker in spinocerebellar ataxia Type 3/Machado-Joseph disease
    Hou, Xiaocan
    Gong, Xuan
    Zhang, Longbo
    Li, Tianjiao
    Yuan, Hongyu
    Xie, Yue
    Peng, Yun
    Qiu, Rong
    Xia, Kun
    Tang, Beisha
    Jiang, Hong
    EPIGENOMICS, 2019, 11 (09) : 1037 - 1055
  • [22] MOLECULAR AND CLINICAL CORRELATIONS IN SPINOCEREBELLAR ATAXIA TYPE-3 AND MACHADO-JOSEPH DISEASE
    MATILLA, T
    MCCALL, A
    SUBRAMONY, SH
    ZOGHBI, HY
    ANNALS OF NEUROLOGY, 1995, 38 (01) : 68 - 72
  • [23] Botulinum toxin type a for treatment of spasticity in spinocerebellar ataxia type 3 (Machado-Joseph disease)
    Freeman, W
    Wszolek, Z
    MOVEMENT DISORDERS, 2005, 20 (05) : 644 - 644
  • [24] MRI T2-Relaxometry in Spinocerebellar Ataxia Type 3 (Machado-Joseph Disease)
    Silva, Beatriz
    Guimaraes, Rachel
    Bergo, Felipe
    Franca, Marcondes
    D'Abreu, Anelyssa
    Lopes-Cendes, Iscia
    Cendes, Fernando
    NEUROLOGY, 2012, 78
  • [25] MRI T2-relaxometry in spinocerebellar ataxia type 3 (Machado-Joseph disease)
    Silva, B. H. B.
    Guimaraes, R.
    Bergo, F.
    Franca, M. C., Jr.
    D'Abreu, A. C. F.
    Lopes-Cendes, I.
    Cendes, F.
    MOVEMENT DISORDERS, 2012, 27 : S232 - S232
  • [26] Spinocerebellar ataxia 3 and Machado-Joseph disease: Clinical, molecular, and neuropathological features
    Durr, A
    Stevanin, G
    Cancel, G
    Duyckaerts, C
    Abbas, N
    Didierjean, O
    Chneiweiss, H
    Benomar, A
    LyonCaen, O
    Julien, J
    Serdaru, M
    Penet, C
    Agid, Y
    Brice, A
    ANNALS OF NEUROLOGY, 1996, 39 (04) : 490 - 499
  • [27] Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3 Machado-Joseph disease
    Cancel, G
    Gourfinkel-An, I
    Stevanin, G
    Didierjean, O
    Abbas, N
    Hirsch, E
    Agid, Y
    Brice, A
    HUMAN MUTATION, 1998, 11 (01) : 23 - 27
  • [28] Vestibulo-ocular arreflexia in families with spinocerebellar ataxia type 3 (Machado-Joseph disease)
    Gordon, CR
    Joffe, V
    Vainstein, G
    Gadoth, N
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (10): : 1403 - 1406
  • [29] Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy
    Matos, Carlos A.
    de Almeida, Luis Pereira
    Nobrega, Clevio
    JOURNAL OF NEUROCHEMISTRY, 2019, 148 (01) : 8 - 28
  • [30] Eye Movement Abnormalities in patients with Spinocerebellar ataxia 3/Machado-Joseph disease
    Ghasia, Fatema Firoz
    Wilmot, George
    Ahmed, Anwar
    Shaikh, Aasef
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)